Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (41-50 of 262) with videos related to

Pageof 27
Sort By:
Aktuelle Urologie|August 11, 2025
[Molecular Tumour Boards for Urological Tumours: Hope or Disappointment?]Nadine Therese Gaisa, Markus Eckstein, Jozefina Casuscelli, et al.
Scientific Reports|October 28, 2024
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporationStefan Soleder, Nicolas Gengenbacher, Carolin Mogler, et al.
International Journal of Clinical and Experimental Pathology|August 11, 2022
Immunohistochemical analysis of sex hormone receptors in squamous changes of the urotheliumJulia B Seitz, Josef Högel, Markus Eckstein, et al.
Oncology Research and Treatment|March 26, 2025
Treatment of Advanced or Metastatic Urothelial CancerThomas Hilser, Christopher Darr, Jens Bedke, et al.
JNCI Cancer Spectrum|April 2, 2023
Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trialJonas Saal, Tobias Bald, Markus Eckstein, et al.
Molecular Oncology|June 10, 2025
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancerLaura Glossner, Markus Eckstein, Christoph Mark, et al.
Cancer Medicine|May 17, 2022
Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts-A follow-upAdrian Holler, Iwona Cicha, Markus Eckstein, et al.
European Urology|August 1, 2024
Membranous expression of target protein is required for ADC response in urothelial cancerNiklas Klümper, Johannes Brägelmann, Veronika Bahlinger, et al.
Expert Opinion on Biological Therapy|February 22, 2020
Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of viewAlessia Cimadamore, Marina Scarpelli, Francesco Massari, et al.
Annals of Translational Medicine|January 14, 2020
PD-L1 assessment in urothelial carcinoma: a practical approachMarkus Eckstein, Alessia Cimadamore, Arndt Hartmann, et al.
Pageof 27

Showing results (41-50 of 262) with videos related to

Sort By:
Pageof 27
Aktuelle Urologie|August 11, 2025
[Molecular Tumour Boards for Urological Tumours: Hope or Disappointment?]Nadine Therese Gaisa, Markus Eckstein, Jozefina Casuscelli, et al.
Scientific Reports|October 28, 2024
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporationStefan Soleder, Nicolas Gengenbacher, Carolin Mogler, et al.
International Journal of Clinical and Experimental Pathology|August 11, 2022
Immunohistochemical analysis of sex hormone receptors in squamous changes of the urotheliumJulia B Seitz, Josef Högel, Markus Eckstein, et al.
Oncology Research and Treatment|March 26, 2025
Treatment of Advanced or Metastatic Urothelial CancerThomas Hilser, Christopher Darr, Jens Bedke, et al.
JNCI Cancer Spectrum|April 2, 2023
Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trialJonas Saal, Tobias Bald, Markus Eckstein, et al.
Molecular Oncology|June 10, 2025
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancerLaura Glossner, Markus Eckstein, Christoph Mark, et al.
Cancer Medicine|May 17, 2022
Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts-A follow-upAdrian Holler, Iwona Cicha, Markus Eckstein, et al.
European Urology|August 1, 2024
Membranous expression of target protein is required for ADC response in urothelial cancerNiklas Klümper, Johannes Brägelmann, Veronika Bahlinger, et al.
Expert Opinion on Biological Therapy|February 22, 2020
Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of viewAlessia Cimadamore, Marina Scarpelli, Francesco Massari, et al.
Annals of Translational Medicine|January 14, 2020
PD-L1 assessment in urothelial carcinoma: a practical approachMarkus Eckstein, Alessia Cimadamore, Arndt Hartmann, et al.
Pageof 27